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The parasitic salmon louse, and its documented resistance to chemotherapeutants, represents the most persistent environmental challenge
to global salmonid aquaculture. We used a genetic marker associated with pyrethroid resistance to analyse 15 000 lice collected from
the North Atlantic in the period 2000–2017. The genotype associated with resistance was not detected in lice collected from throughout the
North Atlantic in the year 2000 or 2002. However, by the year 2009 onwards, it was found in lice from fish farms throughout much of the
North Atlantic. It was also found in modest frequencies in lice collected from wild Atlantic salmon captured off Greenland. The most recent
samples displayed very high frequencies of the genotype associated with resistance, particularly in intensive aquaculture regions of Norway
(>90%) and Scotland (>70%). These results closely align with observations from the field. We suggest that pyrethroid resistance first emerged
in Europe just before or around the year 2000 and was thereafter dispersed throughout much of the North Atlantic where its increased fre-
quency was driven by extensive pyrethroid use. Although the resistant genotype was not detected in lice from Canada, it is likely to occur in
very low frequencies that would quickly increase if pyrethroids were to be used in that region.
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Introduction
All food producing systems are challenged by organisms that slow
down or suppress production. Plant producers have pests and
weeds to fight, while animal breeders are challenged by parasites
and diseases. As a result, most industrial food production is de-
pendent on chemicals to protect crops or stocks (Oerke, 2006;
Alonso-Dı̀az et al., 2014). When pests or parasites develop resis-
tance to chemotherapeutants, consequences can be severe for
food production and security (Clark and Yamaguchi, 2001).
Global salmonid aquaculture also experiences this challenge, and
in marine net-pens where fish are reared, parasitic salmon lice
(Lepeophtheirus salmonis) that have developed resistance to various
chemotherapeutants constitute a major problem (Torrissen et al.,
2013; Aaen et al., 2015; Taranger et al., 2015; Murray et al., 2016).
The salmon louse is an endemic ectoparasitic copepod in the
North Atlantic and Pacific, specializing on salmonids (Kabata,
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1979; Skern-Mauritzen et al., 2014). Chemotherapeutants were
used to control infestations of salmon lice in salmonid aquacul-
ture already in the 1970s (Pike, 1989). Organophosphates were
introduced first (Brandal and Egidius, 1979), followed by pyreth-
roids (Jakobsen and Holm, 1990), hydrogen peroxide (Johnson
et al., 1993), avermectins (Johnson and Margolis, 1993) and ben-
zoylphenyl ureas (Erdal et al., 1997; Ritchie et al., 1997). Repeated
use of a chemotherapeutant drives the development of resistance
(Denholm et al., 2002). Now, salmon lice display reduced sensi-
tivity and/or resistance to all the chemotherapeutents used in
commercial salmonid aquaculture, except the benzoylphenyl
ureas (Aaen et al., 2015; Helgesen et al., 2015, 2019).
Organophosphates were used almost exclusively until resistance
became widespread (Jones et al., 1992) and were replaced by pyr-
ethroids in Norway and other European salmon-producing coun-
tries (Denholm et al., 2002; Sevatdal et al., 2005; Aaen et al.,
2015). The first commercial use of pyrethroids in Norwegian
aquaculture was in 1994, and by 1999, 90% of the delousing
treatments in Norwegian fish farms were based upon pyrethroids
(Denholm et al., 2002). However, reports of treatment failure
were registered in some farms in one county in Norway by 2000
(Sevatdal and Horsberg, 2000, 2003). Indications of reduced sen-
sitivity to pyrethroids were also found through bioassays con-
ducted in Ireland in 2001 and in Scotland in 2002 (Sevatdal et al.,
2005).
Population genetic studies of the salmon louse in the Pacific
(Messmer et al., 2011) and Atlantic Ocean (Todd et al., 2004;
Tjensvoll et al., 2006; Glover et al., 2011) have revealed a species
characterized by extensive gene flow across large regions. By com-
bining population-genomics, linkage-mapping and haplotyping
analysis in parts of the genome where selective sweeps had been
identified, Besnier et al. (2014) demonstrated that resistance to
the delousing chemotherapeutant emamectin benzoate (avermec-
tin) most probably evolved in lice from a single farm source and
was thereafter dispersed to lice throughout the North Atlantic in
<11 years. Similarly, the Phe362Tyr mutation that causes resis-
tance to organophosphates (Kaur et al., 2015) has been found in
lice from all regions of the North Atlantic, although multiple ori-
gins for organophosphate resistance were indicated (Kaur et al.,
2017). The same mutation responsible for organophosphate resis-
tance has also been observed in high frequencies on lice collected
on wild Atlantic salmon (Salmo salar L.) and sea trout (Salmo
trutta L.) in Norway, demonstrating that wild salmonids can both
host and help disperse resistant lice (Fjørtoft et al., 2017). A re-
cent study on pyrethroid resistance from farmed and wild hosts
in Norway, using the same marker of resistance as the present
study, demonstrated the same tendencies (Fjørtoft et al., 2019).
These authors found that pyrethroid-resistant lice existed in high
frequencies on wild sea trout and wild Atlantic salmon returning
from the ocean. Collectively, these studies demonstrate that the
salmon louse is a species in which resistance to chemotherapeutants
can quickly emerge and disperse over vast distances. Studying the
patterns of development and dispersal of resistance provides infor-
mation to advise future management strategies as and when new
chemotherapeutants become commercially available.
Although the exact mode of resistance is not understood, re-
cent investigations have demonstrated that pyrethroid resistance
in L. salmonis is maternally inherited via mitochondrial DNA
(mtDNA) (Nilsen and Espedal, 2015; Carmona-Anto~nanzas et al.,
2017; Bakke et al., 2018). A patented mtDNA genetic marker that
is closely associated with pyrethroid resistance in salmon lice has
also been developed (Nilsen and Espedal, 2015). The marker pat-
ent included extensive phenotyping and genotyping analyses that
collectively validate a non-causative but strong association be-
tween the genotype of lice at the developed marker and survival
of lice in controlled studies as well as in the field (Nilsen and
Espedal, 2015). This marker has been used to genotype 15 000
lice from 200 fish farms in the United Kingdom and Norway to
test sensitivity of lice within cages prior to delousing. In addition,
a set of lice samples spanning the entire North Atlantic in the pe-
riod 2000–2017 have been genotyped with the marker. These data
that provide a unique insight into the spatial and temporal pat-
terns of pyrethroid resistance are presented here.
Methods
Overall study design
The study is based on the following two components: (i) a spa-
tial–temporal analysis of pyrethroid resistance in 1462 lice col-
lected from the North Atlantic in the period 2000–2017 to
investigate resistance dispersal in the pan-Atlantic salmon louse
population and (ii) a high-resolution analysis of pyrethroid resis-
tance of >11 000 lice collected from commercial fish farms in
Norway (2012–2015) and of >3500 lice collected from fish farms
in Scotland (2014–2017) to investigate how resistance disperses
locally under selection.
Genotyping
All of the lice in this study were genotyped using the patented
marker for pyrethroid resistance (Nilsen and Espedal, 2015).
Genotypes resulting from the analysis of this mtDNA marker are
hereon referred to as resistant and sensitive, as mtDNA does not
display recombination and thus heterozygote genotypes. While
the marker does not cause pyrethroid resistance, extensive labora-
tory and field studies documented within the patent, comparing
survival and genotype, demonstrate a strong association between
the marker and the phenotype (Nilsen and Espedal, 2015).
All genotyping was performed by the commercial company
PatoGen AS in their ISO accredited laboratory in Norway. In
short, genotyping consisted of a reverse transcriptase real time/
quantitative polymerase chain reaction (TaqMan) 50-nuclease as-
say using the following primers and probe: forward primer:
TTCTTACAGACAAAGCTAAAGCCACTA, reverse primer:
AGTAACTCCTGCTCACATTCAACCT, and probe: CCCCCCC/
TAACTTAT. A one-step amplification (45 cycles) was performed
on an Applied Biosystems 7500 Real-Time PCR System according
to the manufacturer’s instructions. Resulting genotypes were
scored as resistant or sensitive.
Spatial–temporal analysis of pyrethroid resistance
throughout the North Atlantic 2000–2017
A total of 1462 lice collected from throughout the North Atlantic
in the period 2000–2017 were genotyped. These samples included
753 lice that have been used in previous population genetic and
genomic studies (Tjensvoll et al., 2006; Glover et al., 2011;
Besnier et al., 2014). The majority of these lice was sampled from
fish farms in Northern Europe and Canada but also includes 31
salmon lice sampled from wild Atlantic salmon in Russia in 2000.
In addition, 399 salmon lice were collected from the North
Atlantic in 2016 and 2017. These included lice sampled from
farms in Canada, Iceland, Ireland, Scotland, and the Faroe
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the west coast of Greenland. Samples originating from farmed
fish were collected by farm employees or by fish vet personnel
during routine lice counts or sampling. Samples from wild
salmon were collected by researchers from fish caught by local
fishermen.
In Norway, >11 000 samples of lice were collected from fish
farms in the period 2012–2015 (see below for full description).
For the spatial–temporal analysis across the North Atlantic, we
used salmon lice sampled from fish farms in 2015 from the same
regions where we had samples from 2000 to 2009 to balance the
design (Southern Norway N¼ 38, Western Norway N¼ 2378,
Northern Norway N¼ 746, Finnmark N¼ 149).
A binominal generalized linerar model (GLM) with logit link
function was fitted for the results from the North Atlantic.
logit Yð Þ ¼ aþ b1T þ b2S þ e; (Model 1)
where Y is the frequency of the resistant genotype in each sample,
T is the sampling year, and S is the sampling site.
To avoid numerical singularity when fitting the GLM, an epsi-
lon equal to 0.001 was added to the observed frequency of resis-
tant lice in all samples. This way, all observed frequencies were
strictly greater than zero and the GLM algorithm converged cor-
rectly. A separate binominal GLM with logit link function was fit-
ted for the samples from 2009 to test for differences between
locations. For the regions where data from both 2009 and 2016/
2017 were available, each region was tested separately for differen-
ces over time. Finally, for all samples from Norway, a separate
model was fitted to test for variation in the frequency of resis-
tance both for time and location. The pooled Norwegian data
were compared to the frequency results from the other North
Atlantic locations sampled in 2016 and 2017.
High-resolution screening of pyrethroid resistance in
Norwegian fish farms in the period 2012–2015
A total of 11 326 salmon lice collected from 116 salmon farms
along the Norwegian coast were genotyped. These were sampled
in the period 2012–2015, and some farms were sampled several
times both within and between years. These data were thereafter
used to find the prevalence of the resistant genotype at the mu-
nicipality and county levels.
All delousing treatments are reported to the Norwegian food
safety authorities and are publicly available (BarentsWatch,
2017). The locations and sample dates of the batches of salmon
lice collected from Norwegian fish farms in the period 2012–2015
were aligned to the information on treatments with the pyreth-
roids deltamethrin and cypermethrin. Immediately after a treat-
ment, the prevalence of resistant salmon lice will be higher than
what is representative for the region. To avoid skewness in this di-
rection, a new indicator variable was added to the model, this
new variable had a value of “1” for samples collected from farms
that used pyrethroids within the last 4 weeks before the sample
date and “0” otherwise. Four weeks is the approximate time for
the emergence of one generation of salmon lice after the treat-
ment, dependent on the temperature (Samsing et al., 2016). In to-
tal, genotype results from 10 355 salmon lice sampled at 95
locations were retained for the analyses of spatial and temporal
patterns in Norwegian farms.
The frequency of the resistant genotype in Norwegian farms
was compared between years and regions.
logit Yð Þ ¼ aþ b1T þ b2S þ b3I þ e; (Model 2)
where Y is the frequency of the resistant genotype in each sample,
T is the sampling year, and S is the sampling site. I is a binary in-
dicator that is equal to 1 for all sampled farms that were treated
with pyrethroids 4 weeks or less previous to sampling, and e is a
vector of normally distributed residuals. More information on
model estimates is given in Supplementary Table S1.
High-resolution screening of pyrethroid resistance in
Scottish fish farms in the period 2015–2017
A total of 3532 salmon lice from 77 fish farms in Scotland were
genotyped. Lice originating from the counties Western Isles
(Eilean Siar), Highland, Argyll and Bute, and North Ayrshire
were sampled between 2014 and 2017. For each batch of lice col-
lected from a farm, the number of lice displaying the resistant ge-
notype was reported. These data were used to find the frequency
of the resistant genotype at marine management area and region
levels.
All chemotherapeutant use in Scottish aquaculture is reported
monthly to the authorities (Scotland’s Aquaculture, 2018). By
accessing the information on pyrethroid use for each sampled lo-
cation, we were able to identify farms that had been treated
within the same month or the month before the lice were sam-
pled. As for the Norwegian farm data, a new indicator variable
was added to the model, to identify samples from these farms.
More information on model estimates is given in Supplementary
Table S2. A total of 3292 lice from 58 locations remained, and all
sampled between 2015 and 2017.
To investigate the development in the frequency of resistance
over time and between regions within Scotland, resistance was
modelled as a binary response (R/S) in a GLM with binominal
family as in model 2.
Ethics approval
The salmon louse is not covered by the Norwegian Animal
Welfare Act, nor by the European Convention for the Protection
of Vertebrate Animals used for Experimental and Other Scientific
Purposes, but the host of the salmon louse is.
Salmon lice sampled from 2012 to 2015 in Norway, 2014 to
2017 in Scotland, and 2016 and 2017 in the remaining North
Atlantic were with one exception collected from farmed salmon.
All sampling was conducted with the consent of the fish farmer
and was thus not subject to further licencing. Most lice were sam-
pled during routine lice counting and did not harm the fish. The
Greenlandic salmon lice were sampled from wild Atlantic salmon
caught and killed by local fishermen. Personnel from the National
Oceanic and Atmospheric Administration Fisheries Service col-
lected the lice. The researchers thus took the advantage of ongo-
ing fishery activities and did not contribute to extra mortality on
the wild Atlantic salmon stock. Given the design of the study, fur-
ther consideration by an ethical committee was not necessary.
Results
Spatial–temporal analysis of pyrethroid resistance
throughout the North Atlantic in the period 2000–2017
The resistant genotype was not detected in salmon lice sampled
from wild Russian Atlantic salmon or farmed salmon in Norway
in 2000, nor in lice sampled from fish farms in Canada, Scotland,
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and Norway in 2002 (Figure 1). However, in 2009, it was found
in 99 and 57% of the salmon lice sampled from farms in Shetland
and Ireland, respectively. In the Norwegian samples collected
from fish farms in 2009, the resistant genotype displayed a fre-
quency of 68% in Northern Norway and 28% in Western
Norway. By 2015, the resistant genotype was found in lice from
fish farms in all parts of Norway, with up to 90% in the west. In
the remaining North Atlantic, only samples from fish farms in
Canada remained with no detection of the resistant genotype in
lice sampled in 2017. In the Faroe Islands sample from fish farms
in 2016, the resistant genotype only displayed a frequency of 3%
and was not detected in the 2009 sample. In lice from Iceland,
where delousing chemotherapeutants have never been used in the
time line of relevance for the present study, the resistant genotype
was found in 12% of the sampled lice from fish farms, while it
was found in 20% of the lice sampled from wild Atlantic salmon
in Greenland. In the Irish sample from 2016, the frequency of the
resistant genotype had decreased significantly from the 2009 level
of 57–21% (df ¼ 1, v2 ¼ 20.45, p¼ 6  106), both samples
obtained from farmed salmon. In Scotland, the frequency was
48% in lice sampled from fish farms in 2016. The full dataset is
available in Supplementary Table S3.
There was statistically significant variation in the frequency of
the resistant genotype between the locations sampled in 2009 (df
¼ 8, v2 ¼ 147.8, p< 2  1016). The sample from Canada had no
lice displaying the resistant genotype and was considered as the
reference point for further comparisons. The lice from the Faroes
were not significantly different from the Canadian sample (df ¼
1, v2 ¼ 0.98, p¼ 0.32), but the samples from Ireland, Shetland,
Northern Norway, and Western Norway differed significantly (re-
spectively, df ¼ 1, v2 ¼ 103, p< 2  1016, df ¼ 1, v2 ¼ 332,
p< 2  1016, df ¼ 1,v2 ¼ 284, p< 2  1016, df ¼ 1, v2 ¼ 45,
p¼ 2  1011).
The frequency of the resistant genotype in the Norwegian sam-
ples increased in the time period 2009–2015 (df ¼ 1, v2¼ 204,
p< 2  1016). Geography also contributed to variation, where
southern Norway had a significantly lower frequency of the resis-
tant genotype compared to Finnmark (df ¼ 1, v2¼ 6.0,
p¼ 0.014), while Northern Norway and Western Norway dis-
played significantly higher frequencies (df ¼ 1, v2¼ 95.9, p< 2 
1016 and df ¼ 1, v2¼ 45.5, p¼ 1  1011). The frequency of the
resistant genotype in the pooled Norwegian data from 2015 was
higher (88%) than in all other North Atlantic locations sampled
(27%) (df ¼ 1, v2¼ 712, p< 2  1016).
High-resolution screening of pyrethroid resistance in
Norwegian fish farms in the period 2012–2015
The resistant genotype was detected in high frequencies in lice
sampled from fish farms in all regions of Norway with intensive
aquaculture and was also found in areas with low or minimal sal-
monid production in the southernmost and northernmost parts
of the coast (Figure 2a). The frequency of the resistant genotype
differed significantly between counties (df ¼ 8, v2 ¼ 864, p< 2 
1016). The highest frequencies were found in the counties
Hordaland, Møre og Romsdal, and Sør-Trøndelag, all of which
had average frequencies >90% (Figure 2b). The frequency of the
resistant genotype increased significantly over the 4-year period
(df ¼ 1, v2 ¼ 157, p< 2  1016). For the year 2015, resistance
was between 90 and 95% for all counties from Nordland to
Hordaland (Figure 3). The full dataset is available in
Supplementary Table S4. The farms that were treated 4 weeks or
less previous to sampling had a significantly higher frequency of
resistant genotypes compared to the farms that were not treated
recently (df ¼ 1, v2 ¼ 9.45, p¼ 2  103).
High-resolution screening of pyrethroid resistance in
Scottish fish farms in the period 2015–2017
The resistant genotype was found in lice from farmed fish in all
marine management areas sampled in Scotland (Figure 4a). At
the farm level, the frequency of the resistant genotype ranged
from 13 (Western Isles) to 100% (Strathclyde) (Supplementary
Figure 1. The observed frequency of the pyrethroid-resistant genotype in 1462 lice sampled in the period 2000–2017. Samples marked with
(w) are from wild Atlantic salmon, and all others are from farmed salmon. The number inside the pie charts represents the sample size. The
background map is derived from Global Administrative Areas (2017) and R packages (Becker and Wilks, 1993, 1995; Pebesma and Bivand,
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Table S5). At the regional level, Western Isles had an average fre-
quency of 35%, while Highland had 75% and Strathclyde had
79% (Figure 4b). The difference in frequency of the resistant ge-
notype between the Western Isles and the two other aquaculture
regions was significant (df ¼ 2, v2 ¼ 190, p< 2  1016), and
also Highland and Strathclyde were significantly different from
each other (df ¼ 1, v2¼ 5.2, p¼ 0.022).
The frequency of the resistant genotype decreased from 2015
to 2017 when the whole dataset from Scotland was considered (df
¼ 1, v2 ¼ 28, p¼ 1  107). When both time and region were
considered, there was a significant increase in resistant genotype
frequency in the Western Isles from 2015 to 2017 (df ¼ 1, v2 ¼
8.4, p¼ 3  103), while both Highland and Strathclyde had de-
creased frequencies. This trend was however not statistically
Figure 2. Frequency of the pyrethroid-resistant genotype in 10 355 lice sampled from Norwegian farms. (a) The frequency of the resistant
genotype at the municipality level. (b) The frequency at the county level. The size of the circles in (a) indicates the number of lice analysed,
and the colours in both (a) and (b) indicate the frequency of the resistant genotype in each sample. Lice were sampled in the period 2012–
2015. The background map is derived from Global Administrative Areas (2017) and R packages (Becker and Wilks, 1993, 1995; Pebesma and
Bivand, 2005; Bivand et al., 2013).
Figure 3. Frequency of the pyrethroid-resistant genotype in the counties along the Norwegian coast from north (Finnmark) to south (Agder)
in the years 2012–2015.
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significant for either Highland (df ¼ 1, v2 ¼ 24.6, p¼ 0.10) or
Strathclyde (df ¼ 1, v2 ¼ 1.5, p¼ 0.21) (Figure 5). The full dataset
is available in Supplementary Table S5. The frequency of the re-
sistant genotype was not significantly different between the re-
cently treated farms and the other farms (df ¼ 1, v2 ¼ 0.57,
p¼ 0.45).
Discussion
This study presents the first spatial–temporal analysis of pyre-
throid resistance in the salmon louse, the parasitic copepod that
represents the most persistent challenge to environmentally
sustainable global salmonid aquaculture (Taranger et al., 2015).
We used the recently developed pyrethroid resistance marker
(Nilsen and Espedal, 2015) to genotype 15 000 lice collected
throughout the North Atlantic to investigate the development
and dispersal of resistance in the period 2000–2017. The genotype
associated with resistance was completely absent in all samples of
lice collected throughout the entire North Atlantic up to and in-
cluding the year 2002. However, the resistant genotype was ob-
served throughout most of the European part of the North
Atlantic by 2009 and, by 2017, displayed moderate-to-very high
frequencies in lice from most regions of the North Atlantic. Based
Figure 4. Frequency of the pyrethroid-resistant genotype in 3292 lice sampled from Scottish farms. (a) The frequency of the resistant
genotype at the marine management area level. (b) The frequency at the regional level. The size of the circles in (a) indicates the number of
lice analysed, and the colours in both (a) and (b) indicate the frequency of the resistant genotype in lice from each sample. Lice were sampled
in the period 2015–2017. The background map is derived from Global Administrative Areas (2017) and R packages (Becker and Wilks, 1993,
1995; Pebesma and Bivand, 2005; Bivand et al., 2013).
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upon all available evidence, we suggest that pyrethroid resistance
emerged in Europe in the very late-1990s to early-2000s and was
thereafter rapidly dispersed throughout the North Atlantic,
driven by widespread pyrethroid use. While the resistant geno-
type was not detected in samples from Canada in this study, we
suggest that it probably exists there in a very low frequency and
that local use of pyrethroids would quickly lead to its rapid
selection.
Emergence and dispersal of pyrethroid resistance
throughout the Atlantic
The pattern in the development and dispersal of pyrethroid resis-
tance throughout the North Atlantic, as revealed here (Figure 1),
fits closely with observations of treatment failure and bioassays of
sensitivity from the field (Sevatdal et al., 2005; Whyte et al., 2014;
Helgesen et al., 2019). One of the significant questions is whether
resistance developed in one region and was thereafter rapidly dis-
persed to other regions of the North Atlantic, or alternatively, re-
sistance developed in multiple farms and locations
simultaneously?
In the case of emamectin benzoate resistance, conserved haplo-
types across markers co-located on linkage group 5 of the L. sal-
monis genome, where at least part of emamectin benzoate
resistance is located, demonstrated that resistance to this chemo-
therapeutant primarily emerged as a de novo mutation in one
farm location and was thereafter dispersed rapidly to lice in the
entire Atlantic (Besnier et al., 2014). In contrast, a lack of con-
served haplotypes across markers tightly linked with the
Phe362Tyr mutation causing organophosphate resistance in lice
(Kaur et al., 2015) suggested that organophosphate resistance
most likely originated in multiple farms and locations and was se-
lected for more or less in parallel (Kaur et al., 2017). Due to re-
combination, a nuclear single nucleotide polymorphism (SNP)
under hitchhiking selection with a causative mutation will fade in
its relationship with the associated phenotypic trait from one gen-
eration to the next. In contrast, the pyrethroid resistance marker
used here (Nilsen and Espedal, 2015), while not the cause of resis-
tance (Nilsen and Espedal, 2015; Carmona-Anto~nanzas et al.,
2017; Bakke et al., 2018), remains very tightly, albeit non-
causatively, linked to resistance due to the lack of recombination
in mtDNA. Therefore, the fact that the resistant genotype was not
observed at all in any of the historical samples from 2000 to 2002
but was observed in high or very high frequencies in most of the
samples from Europe by 2009 onwards, suggests that pyrethroid
resistance, as for emamectin benzoate resistance may have pri-
marily originated in a single location and was dispersed thereaf-
ter. This suggestion is also supported from the historical use of
pyrethroids, and the reports of treatment failure, all of which
point to an origin in Europe.
Pyrethroids were introduced and used extensively in European
aquaculture from the late 1990s, but only used for a limited pe-
riod in 2009/2010 in Atlantic Canada (Sevatdal et al., 2005;
Whyte et al., 2014). By 2002, reduced sensitivity had been
reported in farms in Norway, Ireland, and Scotland (Sevatdal and
Horsberg, 2000, 2003; Sevatdal et al., 2005). In our historical ma-
terial, the resistant genotype was not detected before 2009, 10
years after the first reports of treatment failure (Sevatdal and
Horsberg, 2000) and then at frequencies >50% in Northern
Norway and Ireland, and at 99% in the sample from Shetland. By
2017, the resistant genotype was found in all parts of the North
Atlantic, except Canada. These findings indicate a strong selection
for the resistant genotype on the European side, with a subse-
quent dispersal also to areas with no or little pyrethroid use.
Resistant lice sampled from Icelandic farmed salmon and wild
Atlantic salmon caught off Greenland are examples of this.
Neither of these hosts have ever been treated with pyrethroids. In
the 180 lice sampled throughout the North Atlantic by Tjensvoll
et al. (2006) in 2000–2002, 158 different mtDNA haplotypes were
found. This demonstrates a very high diversity in the mtDNA ge-
nome of the salmon louse at the time when pyrethroid resistance
first emerged (Sevatdal and Horsberg, 2000, 2003; Sevatdal et al.,
2005). In comparison, the resistant genotype went from being
completely absent in all of the lice originating from the study by
Tjensvoll et al. (2006) in 2000–2002, to very high frequencies in
most of the European samples by 2016. As the genetic marker
used here is not the causative mutation for pyrethroid resistance
(Nilsen and Espedal, 2015; Carmona-Anto~nanzas et al., 2017;
Bakke et al., 2018), our observations here indicate a primarily sin-
gle origin for pyrethroid resistance. The alternative hypothesis
would be that multiple lice independently obtained the causative
de novo mutation simultaneously with the resistance-associated
SNP genotype used here and were selected for in parallel in sev-
eral regions. This hypothesis appears unlikely given the observed
highly diverse mtDNA genome immediately prior to pyrethroid
resistance emergence. However, unequivocal demonstration of
this requires further analysis.
The resistant genotype was not detected in samples of lice
from fish farms in Canada up to and including 2017. This is not
evidence of genetic isolation of lice across the Atlantic Ocean but
most likely reflects sampling intensity and the lack of pyrethroid
use in that region. The study by Besnier et al. (2014) demon-
strated that a mutation on linkage group 5, causing resistance to
emamectin benzoate, was spread to both sides of the Atlantic
Ocean in 11 years. However, emamectin benzoate was used in
aquaculture both in Canada and Europe; thus, selection for resis-
tance occurred on both sides of the Atlantic. With pyrethroids,
the selection for resistance has only occurred in Europe, with the
exception of the short period of usage on the Canadian side in
2009/2010. During this period, bioassays and lice counting before
and after treatments were conducted in that region to monitor
the effect of the compound (Whyte et al., 2014). Even if the aver-
age effective concentration affecting half the population (EC 50)
values from the bioassays were below the treatment concentra-
tion, an increase in mean EC 50 values from 2009 to 2010 was ob-
served in Canada, which may suggest some very low (and
undetected here) frequency of resistant lice in the short time-
window of pyrethroid usage in that region (Whyte et al., 2014).
The role of wild salmonids as vectors of pyrethroid-resistant
salmon lice has been investigated in a recent study from Norway
(Fjørtoft et al., 2019). In that study, the frequencies of resistant
lice on returning wild Atlantic salmon and wild sea trout were
compared to the frequencies of resistant lice in salmon farms
from the same regions. While there was no significant difference
between the frequencies of resistant lice from wild sea trout and
farmed salmon within a region, the wild Atlantic salmon return-
ing from the ocean carried less resistant lice than the wild sea
trout and the farmed salmon in the areas of intensive aquaculture
(Fjørtoft et al., 2019). These findings elude to the role of wild
Atlantic salmon in dispersing resistant salmon lice. Lice that in-
fect salmon post-smolts migrating from aquaculture regions are
likely to carry the resistant genotype, while the returning adult
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salmon carry a higher frequency of sensitive lice back to their
regions of origin. The reason for this could be that there is a
fitness-cost associated with the resistant genotype. Although this
cannot be ruled out, it is likely that the reduced frequency of re-
sistant salmon lice on returning wild Atlantic salmon is due to a
dilution effect whereby they are infected on the high seas with
sensitive lice originating from salmon that have migrated from
areas without selection for pyrethroid resistance, for example
from Canada. In most aquaculture-producing regions of the
North Atlantic, the number of farmed Atlantic salmon outnum-
bers the number of wild Atlantic salmon. The dilution effect of
the sensitive salmon lice carried back to the Norwegian coast is
unlikely to be high as long as selection for resistance, through
chemical usage, is still practised. However, if pyrethroid usage
was to completely stop, then the sensitive lice carried by the
returning wild salmon to intense farming areas will in time re-
duce the resistance levels. In the same manner, a low frequency of
resistant lice carried to naive areas, such as Iceland and Canada,
may, assuming a low cost of resistance, cause a surprisingly fast
emergence of resistance if pyrethroids were introduced.
Pyrethroid resistance in Europe’s primary salmon-
producing countries: Scotland and Norway
The high-resolution screening of lice from fish farms in Norway
and Scotland demonstrated that the frequency of lice carrying the
resistant genotype is highest in areas of intensive aquaculture
(Figures 2 and 4). This is most likely due to the intensive and on-
going inadvertent selection for resistance through repeated
delousing treatments in aquaculture-dense regions. This is
highlighted by the almost fixation of the resistant genotype in
some of the most aquaculture intense regions (e.g. Western
Norway) compared to lower frequencies in areas where pyreth-
roids have been used less (Finnmark), or not at all (Sørlandet)
(Figure 3). In Scotland, this equates to the differences in resis-
tance marker frequencies between the region Western Isles, with
little aquaculture, and the regions Highland and Strathclyde, with
more intensive aquaculture (Figure 5). The high frequencies of
pyrethroid-resistant lice in these two major aquaculture areas
demonstrate that these chemotherapeutants have a limited useful-
ness for delousing in these regions. This suggestion is supported
by the reports that the number of pyrethroid treatments in aqua-
culture has plummeted from 1155 prescriptions in 2012 to 55 in
2018 in Norway (Helgesen et al., 2019) and from 264 treatments
in 2012 to 60 in 2018 in Scotland (Scotland’s Aquaculture, 2018).
Management implications
In addition to genetic interactions between farmed escapees and
wild conspecifics (Glover et al., 2017), the salmon louse repre-
sents the most persistent challenge to environmentally sustainable
salmon aquaculture (Torrissen et al., 2013; Taranger et al., 2015).
In both the Pacific and Atlantic, salmon lice cause huge economic
losses in the form of reduced productivity and treatment costs
(Costello, 2009a; Iversen et al., 2015) and constitute a challenge
to wild salmonid survival for populations located in the proxim-
ity of farming dense regions (Birkeland and Jakobsen, 1997;
Bjørn and Finstad, 2002; Gargan et al., 2003; Costello, 2009b).
While alternative control measures exist, development of resis-
tance to chemotherapeutants increasingly challenges the indus-
try’s ability to control this parasite as chemotherapeutants have
provided the primary mode of parasite control and probably will
be important also in the future. Therefore, understanding the pat-
terns of emergence and dispersal of resistance in this parasite is of
utmost importance in the continued search for improved man-
agement strategies and to improve the effective life span of new
emerging chemotherapeutants. This is illustrated by the results
here and those from studies looking at emergence and dispersal
of resistance to emamectin benzoate (Besnier et al., 2014) and
organophosphates (Kaur et al., 2017). Collectively, these findings
demonstrate that this parasite is highly capable of developing and
dispersing resistance quickly. This evolutionary capacity is driven
by very large population sizes, high amounts of gene flow over
large distances (Glover et al., 2011; Besnier et al., 2014), rapid
generation times, and that aquaculture represents the primary
driver of salmon louse population dynamics in farming dense
regions (Fjørtoft et al., 2017, 2019). Furthermore, as cross-
infection can occur on the open seas between wild salmon hosts
(Jacobsen and Gaard, 1997), salmon from all parts of the North
Atlantic can be infected with resistant lice in the open ocean
where they meet and thus bring resistant lice back to their coun-
tries. As a result, a large fraction of this species is exposed to che-
motherapeutants over time and the life span of any given
chemotherapeutant is likely to be limited. Therefore, once resis-
tance has developed, it will quickly reach high frequencies and
disperse to other aquaculture areas as long as the chemotherapeu-
tant is used frequently in multiple regions. As such, management
plans aimed at prolonging the effective life of new and emerging
chemotherapeutants need to be agreed upon internationally.
Supplementary data
Supplementary material is available at the ICESJMS online ver-
sion of the manuscript.
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